(NYSE: LLY) Eli Lilly & Co's forecast annual revenue growth rate of 16.01% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 8.62%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.89%.
Eli Lilly & Co's revenue in 2026 is $72,249,500,000.On average, 33 Wall Street analysts forecast LLY's revenue for 2026 to be $81,234,613,681,560, with the lowest LLY revenue forecast at $75,604,883,556,492, and the highest LLY revenue forecast at $92,014,727,556,042. On average, 33 Wall Street analysts forecast LLY's revenue for 2027 to be $94,280,557,378,878, with the lowest LLY revenue forecast at $84,621,115,777,536, and the highest LLY revenue forecast at $108,309,679,104,060.
In 2028, LLY is forecast to generate $105,938,374,243,752 in revenue, with the lowest revenue forecast at $91,690,768,512,378 and the highest revenue forecast at $125,825,127,514,254.